$MCK Income Statement | Understand Stock

$MCK

$992.87 -$7.90 (0.79%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022
Revenues
Cost of sales
Gross profit
Selling, distribution, general, and administrative expenses
Claims and litigation charges, net
Goodwill impairment charges
Restructuring, impairment, and related charges, net
Total operating expenses
Operating income
Other income, net
Equity earnings and charges from investment in Change Healthcare Joint Venture
Loss on debt extinguishment
Interest expense
Income before income taxes
Income tax expense
Income from continuing operations
Loss from discontinued operations, net of tax
Net income
Net income attributable to noncontrolling interests
Net income attributable to McKesson Corporation
Earnings (loss) per common share attributable to McKesson Corporation
Continuing operations (in dollars per share)
Discontinued operations (in dollars per share)
Diluted (in dollars per share)
Basic (in dollars per share)
Weighted-average common shares outstanding
Diluted (in shares)
Basic (in shares)

Comments